title: ESTIC position paper: high-dose chemotherapy for breast cancer, investigation should continue.
authors.affiliation: St. Vincent's Hospital, Dublin, Ireland.
authors.forename: J
authors.initials: J
authors.lastname: Crown
authors.forename: B
authors.initials: B
authors.lastname: Coiffier
authors.forename: H
authors.initials: H
authors.lastname: Cortés-Funes
authors.forename: T
authors.initials: T
authors.lastname: Guillaume
authors.forename: L
authors.initials: L
authors.lastname: Kanz
authors.forename: G
authors.initials: G
authors.lastname: Kvalheim
authors.forename: M
authors.initials: M
authors.lastname: Marty
authors.forename: M
authors.initials: M
authors.lastname: Symann
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000628:therapy*; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D011379:Prognosis; D016896:Treatment Outcome